National Cholesterol Education Panel III performance in preventing myocardial infarction in young adults
- 1. Pharmacy Service Div., Saudi Aramco Medical Services Organization, Dhahran (Saudi Arabia)
- 2. Monla Hospital, Tripoli (Lebanon)
- 3. St. Anthoin Inst. for Nursing, Zgharta (Lebanon)
- 4. Amana Pharmacy, Tripoli (Lebanon)
Description
Only one published has directly evaluated the utility of National Cholesterol Education Program (NCEP) guidelines in young adults that study population consisted of young Americans. We examined the utility of the latest NCEP Adult Treatment Panel III (ATPIII) guidelines in a group of young Lebanese adults. A group of 234 young adults admitted for myocardial infarction at a Lebanese teaching hospital over a 2-year period were evaluated retrospectively. The Framingham risk predictor model was used to calculate the 10-year risk for coronary events in all subjects. Two hundred young Lebanese adults with a mean age of 49+-7.6 years were included in the analysis. The majority of the study population had a history of smoking (67%) and LDL cholesterol <130 mg/dL (70.5%) and were considered overweight and obese (80.5%). As a group, 80% did not meat the criteria to qualify for antilipiemic pharmacotherapy prior to their presentation. The predictive model did not detect the majority of these patients. Clinicians should treat modifiable risk factors with the same intensity given to cholesterol even if the patient has a normal lipid profile. (author)
Additional details
Publishing Information
- Journal Title
- Annals of Saudi Medicine
- Journal Volume
- 28
- Journal Issue
- 1
- Journal Page Range
- p. 22-27
- ISSN
- 0256-4947
INIS
- Country of Publication
- Saudi Arabia
- Country of Input or Organization
- Saudi Arabia
- INIS RN
- 40030305
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ADULTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; DRUGS; HOSPITALS; LIPIDS; MYOCARDIAL INFARCTION; ORGANIC COMPOUNDS; PATIENTS
- Descriptors DEC
- AGE GROUPS; BUILDINGS; CARDIOVASCULAR DISEASES; DISEASES; HYDROXY COMPOUNDS; MEDICAL ESTABLISHMENTS; ORGANIC COMPOUNDS; STEROIDS; STEROLS